Northern Trust Corp Aim Immuno Tech Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Northern Trust Corp holds 85,119 shares of AIM stock, worth $11,065. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,119
Previous 85,119
-0.0%
Holding current value
$11,065
Previous $22,000
22.73%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AIM
# of Institutions
38Shares Held
4.75MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.99MShares$258,5310.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$90,7740.0% of portfolio
-
Geode Capital Management, LLC Boston, MA464KShares$60,3220.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il359KShares$46,6680.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny260KShares$33,8620.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $6.25M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...